cTAPcTAPcTAPcTAP
  • WHAT WE DO
  • HOW WE DO IT
    • Our Leadership
    • OUR SCIENTIFIC ADVISORS
    • Our Approach
  • OUR PROGRAMS
    • cTAP DUCHENNE
    • What’s Next
  • OUR IMPACT
    • Publications
    • Abstracts
    • News & Press
    • Presentations
  • PARTNER WITH US
    • Patient Organizations
    • Scientific Leaders & Researchers
    • Industry
  • CONTACT

A prognostic model for 1 year change in 4SC

Home / Blog / Publications / A prognostic model for 1 year change in 4SC

Deflazacort vs prednisone treatment for Duchenne muscular dystrophy
cTAP Study Shows Real-World, Natural History Data Comparable to Placebo Data from Clinical Trials in Duchenne Muscular Dystrophy

A prognostic model for 1 year change in 4SC

Prognostic factors for changes in the timed 4-stair climb in patients with Duchenne muscular dystrophy, and implications for measuring drug efficacy: A multi-institutional collaboration
Goemans N, Wong B, Van den Hauwe M, Signorovitch J, Sajeev G, Cox D, et al. (2020). PLoS ONE 11(10): e0164684. doi:10.1371/journal.pone.0164684.

View the Full PDF

23
Jun 2020
By SCsbox3AdminPublicationsComments Off on A prognostic model for 1 year change in 4SC

Read the latest

  • Meaningful changes in motor function in Duchenne muscular dystrophy (DMD): A multi-center study
  • Functional trajectories before and after loss of ambulation in Duchenne muscular dystrophy and implications for clinical trials
  • New study may help more DMD patients be included in clinical trials
  • Press release: cTAP Study Indicates DMD Clinical Trial Enrollment Criteria Should Expand Beyond Ambulatory Status
  • Minimal detectable changes in functional measures in Duchenne muscular dystrophy: a study of multiple centers, networks and trial arms

COLLABORATIVE TRAJECTORY
ANALYSIS PROJECT

Cambridge Innovative Center
One Broadway, Cambridge, MA 02142

T: 617-555-5555
E: info@ctap-nmd.org

Terms & Conditions
Privacy Policy

© 2025 Collaborative Trajectory Analysis Project. All rights reserved.

  • WHAT WE DO
  • HOW WE DO IT
    • Our Leadership
    • OUR SCIENTIFIC ADVISORS
    • Our Approach
  • OUR PROGRAMS
    • cTAP DUCHENNE
    • What’s Next
  • OUR IMPACT
    • Publications
    • Abstracts
    • News & Press
    • Presentations
  • PARTNER WITH US
    • Patient Organizations
    • Scientific Leaders & Researchers
    • Industry
  • CONTACT

Terms and Conditions - Privacy Policy